+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urokinase Market - Global Forecast 2025-2030- Product Image
Urokinase Market - Global Forecast 2025-2030- Product Image
Sale

Urokinase Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995126
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urokinase market is rapidly evolving, shaped by innovative manufacturing technologies, an expanding range of clinical applications, and a dynamic global regulatory and economic environment. Senior executives require a clear, actionable overview to navigate growth opportunities, competitive risks, and critical strategic inflection points in this high-value segment.

Market Snapshot: Urokinase Market Size and Growth Trajectory

The Urokinase Market grew from USD 1.85 billion in 2024 to USD 1.95 billion in 2025. It is expected to continue growing at a CAGR of 5.30%, reaching USD 2.52 billion by 2030. This steady market trajectory highlights increasing adoption across multiple clinical domains and underscores the importance of market adaptability for manufacturers, healthcare providers, and distributors. Demand is primarily driven by expanded thrombolytic therapy protocols and increasing cardiovascular care needs in diverse healthcare settings.

Scope & Segmentation of the Urokinase Market

This report provides a comprehensive view into all critical segments of the urokinase sector, ensuring clarity and depth for senior decision-makers exploring investment, product development, and market entry strategies.

  • Product Type: Human urokinase and recombinant urokinase, including platforms based on Escherichia coli and mammalian cell expressions.
  • Form: Liquid solutions and powder formulations supporting varied storage, handling, and clinical workflows.
  • Application: Cardiovascular surgery (spanning coronary artery bypass grafting to valve replacement) and thrombolytic therapy for conditions like acute myocardial infarction and pulmonary embolism.
  • End User: Hospitals, ambulatory surgical centers, specialty clinics, and diagnostic centers.
  • Distribution Channel: Hospital pharmacy, online sales, and retail pharmacy networks.
  • Regions Covered: Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering leading EU countries and Gulf states), and Asia-Pacific (notable markets such as China, India, Japan, Australia, and Southeast Asian nations).
  • Key Technologies: Advanced recombinant expression systems, mammalian cell glycosylation, digital health tools, point-of-care diagnostics, and alternative delivery formats.
  • Company Developments: Medac GmbH, Guangdong Techpool Bio-Pharmaceutical Co., Ltd., Cerbios-Pharma SA, Hanways Chempharm, Kraeber & Co GmbH, Parchem Fine & Specialty Chemicals, Microbix Biosystems Inc., Taj Pharmaceuticals Ltd., Zydus, Wanhua Biochem.

Key Takeaways for Senior Decision-Makers

  • Recombinant urokinase forms are gaining momentum due to improved production scalability, enhanced safety profiles, and consistent product homogeneity, especially when compared to human-derived alternatives.
  • Shifts toward powder formulations are bridging logistic challenges in resource-limited and decentralized clinical environments, supporting broader market adoption.
  • Digital health solutions and predictive diagnostics are enabling more tailored urokinase regimens, accelerating the trend toward personalized medicine and data-driven therapeutic strategies.
  • Partnerships between pharmaceutical companies and contract manufacturing organizations are driving operational agility, vertical integration, and supply chain control, supporting rapid adaptation to market and regulatory shifts.
  • Regional variations in regulatory policies, reimbursement schemes, and technology uptake require customized go-to-market strategies, with growth opportunities particularly robust in fast-expanding Asia-Pacific markets and innovation-focused EMEA hubs.
  • Manufacturers and distributors are increasingly leveraging omni-channel sales approaches and hospital purchasing alliances to expand reach, support cost efficiencies, and address diverse end-user preferences.

Tariff Impact: Navigating New U.S. Trade Policies

Forthcoming U.S. tariff adjustments will directly affect procurement costs and supply chain resilience for urokinase manufacturers, particularly those relying on imported active pharmaceutical ingredients. Stakeholders are expected to navigate these pressures by reevaluating sourcing strategies, exploring nearshoring options, renegotiating contracts with logistics partners, and adopting advanced inventory management tools. These measures are anticipated to mitigate margin impacts and sustain predictable product distribution amid evolving trade conditions.

Methodology & Data Sources

This executive summary is based on a rigorous blend of primary and secondary research. Senior clinical, regulatory, and supply chain leaders were interviewed to provide first-hand, qualitative insights. Secondary data was sourced from peer-reviewed journals, regulatory filings, company reports, and technology roadmaps. Validation workshops and real-world case studies ensured each insight’s relevance and actionability for decision-makers.

The Importance of This Urokinase Market Report

  • Enables informed investment and product-launch decisions by clarifying growth drivers, segment trends, and evolving clinical needs in urokinase therapy.
  • Equips leadership teams with strategic insights to optimize manufacturing, build supply chain resilience, and adapt sales models in the face of tariffs and regional regulatory shifts.
  • Supports the development and commercialization of differentiated offerings by highlighting practical opportunities in technology innovation and patient access across global healthcare ecosystems.

Conclusion

The urokinase market is progressing toward increased sophistication in manufacturing and clinical application. Senior executives equipped with this research will be positioned to respond to market dynamics, seize emerging opportunities, and contribute meaningfully to advances in thrombolytic care worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of targeted nanoparticle-delivery platforms to enhance urokinase stability and reduce systemic hemorrhage risk
5.2. Emergence of biosimilar urokinase candidates intensifying price competition in developed healthcare markets
5.3. Off-label utilization of urokinase for COVID-19-associated pulmonary microthrombosis management in critical care settings
5.4. Advances in ultrasound-assisted catheter-directed urokinase delivery to minimize dosage and bleeding complications
5.5. Expansion of regulatory approvals for urokinase therapies in BRICS nations driving market penetration and access
5.6. Development of lyophilized urokinase formulations for improved shelf life and ease of hospital inventory management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urokinase Market, by Product Type
8.1. Introduction
8.2. Human Urokinase
8.3. Recombinant Urokinase
8.3.1. Escherichia Coli Expression
8.3.2. Mammalian Cell Expression
9. Urokinase Market, by Form
9.1. Introduction
9.2. Liquid Solution
9.3. Powder
10. Urokinase Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.2.1. Coronary Artery Bypass Grafting
10.2.2. Valve Replacement
10.3. Thrombolytic Therapy
10.3.1. Acute Myocardial Infarction
10.3.2. Pulmonary Embolism
11. Urokinase Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Specialty Clinics
12. Urokinase Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Sales
12.4. Retail Pharmacy
13. Americas Urokinase Market
13.1. Introduction
13.2. United States
13.3. Brazil
13.4. Argentina
13.5. Canada
13.6. Mexico
14. Europe, Middle East & Africa Urokinase Market
14.1. Introduction
14.2. France
14.3. Germany
14.4. South Africa
14.5. United Kingdom
14.6. Switzerland
14.7. United Arab Emirates
14.8. Egypt
14.9. Nigeria
14.10. Finland
14.11. Qatar
14.12. Turkey
14.13. Saudi Arabia
14.14. Netherlands
14.15. Italy
14.16. Denmark
14.17. Poland
14.18. Sweden
14.19. Spain
14.20. Norway
14.21. Russia
14.22. Israel
15. Asia-Pacific Urokinase Market
15.1. Introduction
15.2. Indonesia
15.3. Singapore
15.4. Australia
15.5. Malaysia
15.6. Japan
15.7. Vietnam
15.8. Philippines
15.9. India
15.10. China
15.11. Thailand
15.12. Taiwan
15.13. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medac GmbH
16.3.2. Guangdong Techpool Bio-Pharmaceutical Co., Ltd.
16.3.3. Cerbios-Pharma SA
16.3.4. Hanways Chempharm
16.3.5. Kraeber & Co GmbH
16.3.6. Parchem Fine & Specialty Chemicals
16.3.7. Microbix Biosystems Inc.
16.3.8. Taj Pharmaceuticals Ltd.
16.3.9. Zydus
16.3.10. Wanhua Biochem
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. UROKINASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL UROKINASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UROKINASE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL UROKINASE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UROKINASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL UROKINASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UROKINASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. UROKINASE MARKET: RESEARCHAI
FIGURE 26. UROKINASE MARKET: RESEARCHSTATISTICS
FIGURE 27. UROKINASE MARKET: RESEARCHCONTACTS
FIGURE 28. UROKINASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. UROKINASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL UROKINASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL UROKINASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL UROKINASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL UROKINASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL UROKINASE MARKET SIZE, BY HUMAN UROKINASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL UROKINASE MARKET SIZE, BY HUMAN UROKINASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL UROKINASE MARKET SIZE, BY ESCHERICHIA COLI EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL UROKINASE MARKET SIZE, BY ESCHERICHIA COLI EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL UROKINASE MARKET SIZE, BY MAMMALIAN CELL EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL UROKINASE MARKET SIZE, BY MAMMALIAN CELL EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL UROKINASE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL UROKINASE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL UROKINASE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL UROKINASE MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL UROKINASE MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL UROKINASE MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL UROKINASE MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL UROKINASE MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL UROKINASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL UROKINASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL UROKINASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL UROKINASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL UROKINASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL UROKINASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL UROKINASE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL UROKINASE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL UROKINASE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL UROKINASE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. CANADA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 134. CANADA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 135. CANADA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 136. CANADA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 137. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 140. CANADA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 141. CANADA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 142. CANADA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 143. CANADA UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 152. MEXICO UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 153. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. FRANCE UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. FRANCE UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. FRANCE UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 184. FRANCE UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 185. FRANCE UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 186. FRANCE UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 187. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 190. FRANCE UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 191. FRANCE UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 192. FRANCE UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 193. FRANCE UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. FRANCE UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. FRANCE UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. FRANCE UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 202. GERMANY UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 203. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. SOUTH AFRICA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SWITZERLAND UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. SWITZERLAND UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. SWITZERLAND UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 248. SWITZERLAND UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 249. SWITZERLAND UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 250. SWITZERLAND UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 251. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SWITZERLAND UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 254. SWITZERLAND UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 255. SWITZERLAND UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 256. SWITZERLAND UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 257. SWITZERLAND UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SWITZERLAND UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EGYPT UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. EGYPT UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. EGYPT UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 280. EGYPT UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 281. EGYPT UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 282. EGYPT UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 283. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. EGYPT UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 286. EGYPT UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 287. EGYPT UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 288. EGYPT UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 289. EGYPT UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. EGYPT UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. EGYPT UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. EGYPT UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. NIGERIA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. NIGERIA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. NIGERIA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 296. NIGERIA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 297. NIGERIA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 298. NIGERIA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 299. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. NIGERIA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 302. NIGERIA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 303. NIGERIA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 304. NIGERIA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. FINLAND UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. FINLAND UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. FINLAND UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 312. FINLAND UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 313. FINLAND UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 314. FINLAND UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 315. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. FINLAND UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 318. FINLAND UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 319. FINLAND UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 320. FINLAND UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 321. FINLAND UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. FINLAND UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. FINLAND UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. FINLAND UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. QATAR UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. QATAR UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. QATAR UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 328. QATAR UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 329. QATAR UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 330. QATAR UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 331. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. QATAR UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 334. QATAR UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 335. QATAR UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 336. QATAR UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 337. QATAR UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. QATAR UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. QATAR UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. QATAR UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. TURKEY UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. TURKEY UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. TURKEY UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 344. TURKEY UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 345. TURKEY UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 346. TURKEY UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 347. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. TURKEY UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 350. TURKEY UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 351. TURKEY UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 352. TURKEY UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 353. TURKEY UROKINASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. TURKEY UROKINASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. TURKEY UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. TURKEY UROKINASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. SAUDI ARABIA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 358. SAUDI ARABIA UROKINASE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 359. SAUDI ARABIA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2018-2024 (USD MILLION)
TABLE 360. SAUDI ARABIA UROKINASE MARKET SIZE, BY RECOMBINANT UROKINASE, 2025-2030 (USD MILLION)
TABLE 361. SAUDI ARABIA UROKINASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 362. SAUDI ARABIA UROKINASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 363. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 364. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 365. SAUDI ARABIA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 366. SAUDI ARABIA UROKINASE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 367. SAUDI ARABIA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 368. SAUDI ARABIA UROKINASE MARKET SIZE, BY THROMBOLYTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 369. SAUDI ARABIA UROKINASE MARKET SIZE, BY END USER, 2018-202

Samples

Loading
LOADING...

Companies Mentioned

  • Medac GmbH
  • Guangdong Techpool Bio-Pharmaceutical Co., Ltd.
  • Cerbios-Pharma SA
  • Hanways Chempharm
  • Kraeber & Co GmbH
  • Parchem Fine & Specialty Chemicals
  • Microbix Biosystems Inc.
  • Taj Pharmaceuticals Ltd.
  • Zydus
  • Wanhua Biochem

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.52 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Urokinase - Global Strategic Business Report - Product Image

Urokinase - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Urokinase Market Report 2025 - Product Image

Urokinase Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Myocardial Infarction Treatment Enzyme Market - Global Forecast 2025-2030 - Product Image

Myocardial Infarction Treatment Enzyme Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Thrombolytic Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Thrombolytic Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 130 Pages
  • Global
From
Thrombolytic Drug Market - Global Forecast 2025-2030 - Product Image

Thrombolytic Drug Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From

About the Urokinase Market

Urokinase is a type of cardiovascular drug used to treat a variety of conditions, including pulmonary embolism, deep vein thrombosis, and acute myocardial infarction. It is a thrombolytic agent, meaning it works by breaking down blood clots and restoring blood flow to the affected area. Urokinase is administered intravenously and is typically used in combination with other medications. It is also used to prevent the formation of new blood clots. Urokinase is a widely used drug in the cardiovascular market, with a variety of manufacturers offering it in different forms. It is available in both generic and branded versions, with the latter being more expensive. The drug is also available in different concentrations, depending on the patient's needs. Some of the companies in the Urokinase market include Pfizer, Sanofi, Merck, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.